Results 131 to 140 of about 15,339 (215)

#2567 Protein-bound uremic toxins are better removed with short-daily Home Haemodialysis using low dialysate flow rate: randomized clinical trial results

open access: yesNephrology, Dialysis and Transplantation
Short daily home hemodialysis (HDD) with low dialysate flow rate has been shown in recent years as an attractive alternative for portable dialysis home use.
M. Moya   +11 more
semanticscholar   +1 more source

Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients—A Randomized Controlled Clinical Trial [PDF]

open access: yes, 2017
Background To increase the removal of middle-sized uremic toxins a new membrane with enhanced permeability and selectivity, called Medium Cut-Off membrane (MCO-Ci) has been developed that at the same time ensures the retention of albumin.
Boehler, Torsten [u.a.]   +7 more
core   +1 more source

Protein-Bound Uremic Toxins Binding to Human Serum Albumin

open access: yesEducation and Research Archive
Kidney failure is a global health concern, exacerbated by the accumulation of uremic metabolites that persist despite conventional treatments such as hemodialysis (HD). A significant subset of these metabolites, termed protein-bound uremic toxins (PBUTs), bind tightly to human serum albumin (HSA), limiting their removal through traditional separation ...
openaire   +1 more source

Effect of Oral N-acetylcysteine Treatment on Immune System in Continuous Ambulatory Peritoneal Dialysis Patients [PDF]

open access: yes, 2012
Tujuan: mengevaluasi efek N-asetilsistein (NAS) oral terhadap kadar petanda inflamasi pada pasien Continuous Ambulatory Peritoneal Dialysis (CAPD).
Prasetyo, Diding H., Purwanto, Bambang
core   +1 more source

Development of hybrid kidney for removal of protein-bound anionic uremic toxins [PDF]

open access: yes, 2011
課題番号 ...
Tsuruoka Shuichi, 鶴岡 秀一
core  

Narrative Review of Incremental Hemodialysis. [PDF]

open access: yes, 2020
The prescription of hemodialysis (HD) in patients with incident end-stage kidney disease (ESKD) is fundamentally empirical. The abrupt transition from nondialysis chronic kidney disease (CKD) to thrice-weekly in-center HD of much the same dialysis ...
Garneata, Liliana   +3 more
core  

Fluorinated Zirconium‐Based Metal‐Organic Frameworks as Novel Sorbents to Improve the Efficacy of Hemodialysis Treatment

open access: yesSmall Science
People with end‐stage chronic kidney disease (CKD) require routine dialysis treatments to remove uremic toxins from the blood in order to minimize toxic symptoms.
Fátima Guerrero   +4 more
doaj   +1 more source

Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma. [PDF]

open access: yes, 2019
The aryl hydrocarbon receptor (AhR) is a well-known ligand-activated cytoplasmic transcription factor that contributes to cellular responses against environmental toxins and carcinogens.
Chen, Lin   +8 more
core   +1 more source

The influence of uremic toxins on low bone turnover disease in chronic kidney disease

open access: yesTzu Chi Medical Journal
Uremic toxins play a crucial role in the development of low bone turnover disease in chronic kidney disease (CKD) through the induction of oxidative stress.
Giou-Teng Yiang   +6 more
doaj   +1 more source

Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD

open access: yesKidney International Reports
INTRODUCTION: Furosemide is commonly prescribed to patients with chronic kidney disease (CKD) but may impair the kidney’s excretion of protein-bound uremic toxins (PBUTs) via the organic anion transporters 1 and 3 (OAT1 and OAT3). We evaluated the association between furosemide prescription (status and dose level) and the serum concentrations of free ...
Margaux Costes-Albrespic   +29 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy